Quick Answer
Altamira Therapeutics Ltd. reported Stockholders Equity of $16.77 million for the year ending 2020.
- Altamira Therapeutics Ltd. showed an increase of +177.8% in Stockholders Equity from 2019 to 2020.
- This data is from Altamira Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2021.
- XBRL data for this metric is available from 2019 to 2020 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2020: $16.77 million | Fiscal year 2019: $6.04 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: